Tag: decisions

AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity

Transaction in Own Shares

Transaction in Own Shares

TGS Awarded Offshore Wind Site Characterization Contract in Europe

OSLO, Norway (9 June 2026) – TGS, a leading provider of energy data and intelligence, is pleased to announce the award of an offshore wind site characterization contract in Europe. The Ramform Vanguard is scheduled to commence data acquisition in early August, and the contract has a duration of approximately three weeks.

Defiance Launches MUZ: The First 2X Short ETF for Micron Technology, Inc.

Aware Expands Awareness Platform Capabilities with Key Partnerships to Deliver Smarter Identity Decisions

New enhancements combined with ROC and Mitek capabilities help organizations strengthen fraud prevention and user experience with real time biometric orchestration and decisioning

New enhancements combined with ROC and Mitek capabilities help organizations strengthen fraud prevention and user experience with real time biometric orchestration and decisioning

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., June 8, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public offering of common...

Think Digital, a Division of Think Education, Launches Raly Report to Streamline LCAP Development for California Education Leaders

AI-powered platform reduces administrative resources and helps leaders focus on student outcomesSANTA ANA, Calif., June 8, 2026 /PRNewswire/ -- Think Digital, a division of...

Sirius XM Holdings Set to Join S&P MidCap 400

NEW YORK, June 8, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior...

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.

/R E P E A T — NOTICE TO THE MEDIA – Media Availability on Federal Actions in Response to the Illegal Drug Crisis/

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading

AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity

Transaction in Own Shares

TGS Awarded Offshore Wind Site Characterization Contract in Europe

Defiance Launches MUZ: The First 2X Short ETF for Micron Technology, Inc.

Aware Expands Awareness Platform Capabilities with Key Partnerships to Deliver Smarter Identity Decisions

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

Think Digital, a Division of Think Education, Launches Raly Report to Streamline LCAP Development for California Education Leaders

Sirius XM Holdings Set to Join S&P MidCap 400

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

HelloNation Article Featuring Insurance Expert Jose Gomez Shares Cheapest Car Insurance Tips in Illinois

The Government of Canada launches public consultations on the future of Billy Bishop Toronto City Airport

Northfield Park Racino Selects Tangam’s Slot Optimization (SODA) Platform

Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer

West Monroe Launches WestMonroe.ai, Making AI Agents for Business Strategy Publicly Available

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us